Vertex Pharmaceuticals Inc (VRTX) — Quality & forensics
As of 2026-09-21 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.
The Closelook module scores
- Valuation 29
- Quality 86
- Growth 50
- Balance sheet 86
- Cash quality 21
- Capital allocation 43
- Momentum 65
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the VRTX chart & overview · the earnings record · VRTX on the tape
FAQ · from the current data · as of 2026-09-21
Quick answers
What is Vertex Pharmaceuticals Inc's Closelook quality reading?
The composite reads 57/100 across 7 modules, as of 2026-09-21: valuation 29, quality 86, growth 50, balance sheet 86, cash quality 21, capital allocation 43, momentum 65. Closelook scores are research diary readings, not ratings or investment advice.
What is Vertex Pharmaceuticals Inc's Altman Z-Score?
12.59, which sits in the safe zone (above 2.99) as of 2026-09-21. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Vertex Pharmaceuticals Inc's Piotroski F-Score?
5 of 8, as of 2026-09-21. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Vertex Pharmaceuticals Inc's Beneish M-Score indicate?
-2.20 — below the −1.78 manipulation-risk threshold, as of 2026-09-21. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Mentioned on Closelook
Where VRTX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelook universe
same Closelook index seat first, then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- RACE Ferrari NV
- DECK Deckers Outdoor Corporation
- DXCM DexCom Inc
- LLY Eli Lilly and Company
- FSLR First Solar Inc
- REGN Regeneron Pharmaceuticals Inc
- TOST Toast Inc
- VWS.CO Vestas Wind Systems A/S
- ZEAL.CO Zealand Pharma A/S
- ERJ Embraer S.A.
- DB1.DE Deutsche Börse AG
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry